Clonal culture of human pluripotent stem cells

• US 7,892,830 B2
• Filed: 01/17/2008
• Issued: 02/22/2011
• Est. Priority Date: 01/17/2007
• Status: Active Grant

• Current Assignee: Wisconsin Alumni Research Foundation (University of Wisconsin System)
• Original Assignee: Wisconsin Alumni Research Foundation (University of Wisconsin System)
• Inventors: Bergendahl, Veit, Thomson, James A.
• Primary Examiner(s): Ton; Thaian N
• Application Number:
  US12/016,066
• Publication Number:
  US 20080171385A1
• Time in Patent Office: 1,132 Days
• Field of Search: 435/384, 435/325, 435/366, 435/383, 435/402, 435/404, 435/405
• US Class Current: 435/384
• CPC Class Codes: C12N 2501/70 Enzymes
• CPC Class Codes: C12N 2501/999 Small molecules not provided for elsewhere
• CPC Class Codes: C12N 5/0606 Pluripotent embryonic cells, e.g. embryonic stem cells [ES] embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696

Abstract

While culture medium and systems have been described that permit the culture and proliferation of human embryonic stem cells in feeder free and animal product free conditions, these conditions will not readily support cloning of an embryonic stem cell culture meaning, at least here, the initiation of a sub-culture using one or a very few originating cells. It has been found here that a class of small molecules that are inhibitors of kinase enzymes will increase the efficiency of cloning of stem cell cultures sufficiently to make such cloning practical in the defined medium and in other media as well.

Claims

1. A method of creating a clonal culture of human pluripotent stem cells comprising the steps of:

providing a culture of human pluripotent stem cells in culture in a fibroblast growth factor-containing culture medium in a culture vessel;

selecting a single pluripotent stem cell from the stem cells in culture;

initiating a new culture of pluripotent stem cells with the single pluripotent stem cell in a culture vessel containing an extracellular matrix coating a surface inside the culture vessel and a fibroblast growth factor-containing culture medium, the culture medium including an agent selected to increase the cloning efficiency of the pluripotent stem cell culture relative to a pluripotent stem cell culture that does not contain the agent, the agent being a small molecule having the formula;

2. The method as claimed in claim 1, wherein the agent is a kinase inhibitor.

3. The method as claimed in claim 1, wherein the agent is a protein kinase A inhibitor, a protein kinase C inhibitor, a protein kinase G inhibitor or a Rho-associated kinase (ROCK) inhibitor.

4. The method as claimed in claim 1, wherein the agent is selected from the group consisting of

5. A method of creating a clonal culture of human pluripotent stem cells comprising the steps of;

providing a culture of human pluripotent stem cells in culture in a fibroblast growth factor-containing culture medium in a culture vessel;

selecting a single pluripotent stem cell from the stem cells in culture;

initiating a new culture of pluripotent stem cells with the single pluripotent stem cell in a culture vessel containing an extracellular matrix coating a surface inside the culture vessel and a fibroblast growth factor-containing culture medium, the culture medium including an agent selected to increase the cloning efficiency of the pluripotent stem cell culture relative to a pluripotent stem cell culture that does not contain the agent, the agent being selected from the group consisting of

6. A human pluripotent stem cell culture comprising:

a culture vessel containing an extracellular matrix coating a surface inside the culture vessel;

a fibroblast growth factor-containing culture medium;

human pluripotent stem cells growing in the fibroblast growth factor-containing culture medium; and

the fibroblast growth factor-containing culture medium containing an agent selected to increase the cloning efficiency of the stem cell culture relative to a stem cell culture that does not contain the agent, the agent being a kinase inhibitor having the formula;

7. A human pluripotent stem cell culture of claim 6, wherein the agent is selected from the group consisting of

8. An improvement in a fibroblast growth factor-containing medium in which to culture relative to a stem cell culture medium that does not contain the agent human pluripotent stem cells, the improvement comprising including in the medium an agent selected to increase the cloning efficiency of the stem cell culture, wherein the agent is selected from the group consisting of